Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Accumulated Expenses (2020 - 2025)

IceCure Medical has reported Accumulated Expenses over the past 6 years, most recently at $2.7 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 3.55% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $2.7 million, down 3.55%, while the annual FY2025 figure was $2.7 million, 3.55% down from the prior year.
  • Accumulated Expenses was $2.7 million for Q4 2025 at IceCure Medical, down from $2.8 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $3.1 million in Q4 2023 and bottomed at $554000.0 in Q4 2022.
  • The 5-year median for Accumulated Expenses is $2.8 million (2024), against an average of $2.4 million.
  • Year-over-year, Accumulated Expenses plummeted 80.99% in 2022 and then soared 467.87% in 2023.
  • Over 5 years, Accumulated Expenses stood at $2.9 million in 2021, then plummeted by 80.99% to $554000.0 in 2022, then soared by 467.87% to $3.1 million in 2023, then fell by 12.36% to $2.8 million in 2024, then fell by 3.55% to $2.7 million in 2025.
  • The last three reported values for Accumulated Expenses were $2.7 million (Q4 2025), $2.8 million (Q4 2024), and $3.1 million (Q4 2023) per Business Quant data.